Global Information
회사소개 | 문의 | 비교리스트

세계의 항고혈압제 시장 분석 : 치료 클래스별·유통채널별·지역별 예측

Global Antihypertensive Drugs Market Size study, by Therapeutic Class, by Distribution Channel and Regional Forecasts 2020-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2020년 06월 상품 코드 946923
페이지 정보 영문
가격
US $ 4,950 ₩ 5,847,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,383,000 Printable PDF (Enterprise License)


세계의 항고혈압제 시장 분석 : 치료 클래스별·유통채널별·지역별 예측 Global Antihypertensive Drugs Market Size study, by Therapeutic Class, by Distribution Channel and Regional Forecasts 2020-2027
발행일 : 2020년 06월 페이지 정보 : 영문

세계 항고혈압제 시장은 2019년 2,320만 달러 규모에 달했으며, 2020-2027년간 3.1% 이상의 성장률로 성장할 전망입니다. 최근의 코로나19(Covid-19) 팬데믹에 의해 항고혈압제 복용에 의한 호흡기 관련 위험 회피가 권장되게 되었고, 그것이 시장 성장 주요인이 될 것으로 예측됩니다.

세계의 항고혈압제(Antihypertensive Drugs) 시장을 분석했으며, 시장의 기본 구조(밸류체인), 주요 성장 촉진요인 및 억제요인, 전체적인 시장 규모 동향 전망(향후 8년간), 치료 카테고리별·유통채널별·지역별 상세 동향, 주요 기업 프로파일 및 시장 점유율 등의 정보를 정리하여 전해드립니다.

제1장 개요

제2장 세계의 항고혈압제 시장 : 정의와 범위

제3장 세계의 항고혈압제 시장 : 시장 역학

  • 항고혈압제 시장에 미치는 영향 요인 분석

제4장 세계의 항고혈압제 시장 : 산업 분석

  • Porter's Five Forces 분석
  • PEST 분석
  • 투자/도입 모델
  • 애널리스트의 제안 및 결론

제5장 세계의 항고혈압제 시장 : 치료 카테고리별

  • 시장 상황 개요
  • 시장 실적 치료 카테고리별 : 장래성 분석
  • 시장 추정 및 예측 : 치료 클래스별(금액 기준)
  • 하위 부문 분석
    • 이뇨제
    • Angiotensin-Converting Enzyme (ACE)억제제
    • 칼슘 채널 차단제
    • 혈관 확장제
    • 베타 아드레날린 차단제
    • 기타

제6장 세계의 항고혈압제 시장 : 유통채널별

  • 시장 상황 개요
  • 시장 실적, 유통채널별 : 장래성 분석
  • 시장 추정 및 예측 : 유통채널별(금액 기준)
  • 하위 부문 분석
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제7장 세계의 항고혈압제 시장 : 지역별 분석

  • 지역별 시장 상황 개요
  • 북미 시장
    • 미국
    • 캐나다
  • 유럽 시장
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽 국가
  • 아시아태평양 시장
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양 국가
  • 라틴아메리카 시장
    • 브라질
    • 멕시코
  • 기타 국가 시장(RoW)

제8장 기업 정보

  • 주요 시장 전략
  • 기업 개요
    • Boehringer Ingelheim International GmbH
    • Merck & Co., KGaA
    • Johnson and Johnson
    • Bayer AG
    • Pfizer, Inc.
    • Takeda Pharmaceutical Co. Ltd.
    • AstraZeneca plc
    • Daiichi Sankyo Company, Ltd.
    • Sanofi SA
    • Novartis International AG

제9장 조사 과정

LSH 20.07.17

LIST OF TABLES

List of Tables

  • TABLE 1. Global Antihypertensive Drugs market, report scope
  • TABLE 2. Global Antihypertensive Drugs market estimates & forecasts by region 2017-2027 (USD Million)
  • TABLE 3. Global Antihypertensive Drugs market estimates & forecasts by Therapeutic Class 2017-2027 (USD Million)
  • TABLE 4. Global Antihypertensive Drugs market estimates & forecasts by Distribution Channel 2017-2027 (USD Million)
  • TABLE 5. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 6. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 7. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 8. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 9. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 10. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 11. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 12. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 13. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 14. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 15. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 16. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 17. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 18. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 19. Global Antihypertensive Drugs market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 20. Global Antihypertensive Drugs market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 21. U.S. Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 22. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 23. U.S. Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 24. Canada Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 25. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 26. Canada Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 27. UK Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 28. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 29. UK Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 30. Germany Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 31. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 32. Germany Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 33. France Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 34. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 35. France Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 36. Spain Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 37. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 38. Spain Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 39. Italy Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 40. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 41. Italy Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 42. ROE Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 43. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 44. ROE Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 45. China Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 46. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 47. China Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 48. India Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 49. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 50. India Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 51. Japan Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 52. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 53. Japan Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 54. Australia Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 55. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 56. Australia Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 57. South Korea Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 58. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 59. South Korea Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 60. ROPAC Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 61. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 62. ROPAC Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 63. Brazil Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 64. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 65. Brazil Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 66. Mexico Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 67. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 68. Mexico Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 69. ROLA Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 70. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 71. ROLA Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 72. ROW Antihypertensive Drugs market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 73. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 74. ROW Antihypertensive Drugs market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 75. List of secondary sources, used in the study of global Antihypertensive Drugs market
  • TABLE 76. List of primary sources, used in the study of global Antihypertensive Drugs market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Antihypertensive Drugs market, research methodology
  • FIG 2. Global Antihypertensive Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Antihypertensive Drugs market, key trends 2019
  • FIG 5. Global Antihypertensive Drugs market, growth prospects 2020-2027
  • FIG 6. Global Antihypertensive Drugs market, porters 5 force model
  • FIG 7. Global Antihypertensive Drugs market, pest analysis
  • FIG 8. Global Antihypertensive Drugs market, value chain analysis
  • FIG 9. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 10. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 11. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 12. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 13. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 14. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 15. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 16. Global Antihypertensive Drugs market by segment, 2017 & 2027 (USD Million)
  • FIG 17. Global Antihypertensive Drugs market, regional snapshot 2017 & 2027
  • FIG 18. North America Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 19. Europe Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 20. Asia-Pacific Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 21. Latin America Antihypertensive Drugs market 2017 & 2027 (USD Million)
  • FIG 22. Global Antihypertensive Drugs market, company market share analysis (2019)

Title:
Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027.

Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Antihypertensive drug is the class of drug used in the treatment of hypertension (high blood pressure). Hypertension is one of the leading causes of heart complications, such as heart failure, heart attack, and dementia. Thus, the treatment of hypertension must be integrated into an overall program to manage factors that intensify the risk of cardiovascular events (such as stroke and myocardial infarction). Therefore, there are a variety of antihypertensive drugs has been developed for treating hypertension. Some of the major antihypertensive drugs are thiazide diuretics, beta-adrenoceptor antagonists (beta-blockers), dihydropyridine calcium-channel blockers, and many more. These drugs can reduce the blood pressure rates and can prevent the health complications associated with high blood pressure. Therefore, these factors are anticipated to accelerate the market growth around the world. Moreover, the rise in cases of hypertension across the globe, followed by the growing elderly population are few other factors responsible for the market growth over the forecast period. According to the World Health Organization (WHO), around 1.3 billion people have hypertension around the world. Also, the possibility of its prevalence increases with age. As per the Framingham Heart Study, hypertension eventually developed in over 90% of participants with normal blood pressure at 55 years of age. By age 60 years of age, nearly 60% of the population has hypertension, by 70 years, about 65% of men and 75% of women have hypertension. This, in turn, is likely to accelerate the demand for drugs all over the world. Recently, the COVID-19 is widely spread throughout the world, thus various regional governments are mandating the use of drugs among the patients to prevent or mitigate the risk of respiratory-related problems. This is likely to strengthen the usage for antihypertensive drugs that encourage the manufacturers to produce them thereby, the market would grow at a significant rate in the forthcoming years. However, side-effects related to the use of drugs is one of the major factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antihypertensive Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rise in prevalence of hypertension, along with the significant initiatives opt by the market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising geriatric population and increasing incidences of heart attack and failures among people would create lucrative growth prospects for the Antihypertensive Drugs market across the Asia-Pacific region.

Major market player included in this report are:

Boehringer Ingelheim International GmbH

Merck & Co., KGaA

Johnson and Johnson

Bayer AG

Pfizer, Inc.

Takeda Pharmaceutical Co. Ltd.

AstraZeneca plc

Daiichi Sankyo Company, Ltd.

Sanofi S.A.

Novartis International AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapeutic Class:

Diuretics

Angiotensin-Converting Enzyme (ACE) Inhibitors

Calcium Channel Blockers

Vasodilators

Beta-adrenergic Blockers

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Antihypertensive Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. Antihypertensive Drugs Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. Antihypertensive Drugs Market, by Therapeutic Class, 2018-2027 (USD Million)
    • 1.2.3. Antihypertensive Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antihypertensive Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antihypertensive Drugs Market Dynamics

  • 3.1. Antihypertensive Drugs Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Antihypertensive Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antihypertensive Drugs Market, by Therapeutic Class

  • 5.1. Market Snapshot
  • 5.2. Global Antihypertensive Drugs Market by Therapeutic Class, Performance - Potential Analysis
  • 5.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Therapeutic Class 2017-2027 (USD Million)
  • 5.4. Antihypertensive Drugs Market, Sub Segment Analysis
    • 5.4.1. Diuretics
    • 5.4.2. Angiotensin-Converting Enzyme (ACE) Inhibitors
    • 5.4.3. Calcium Channel Blockers
    • 5.4.4. Vasodilators
    • 5.4.5. Beta-adrenergic Blockers
    • 5.4.6. Others

Chapter 6. Global Antihypertensive Drugs Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Antihypertensive Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Million)
  • 6.4. Antihypertensive Drugs Market, Sub Segment Analysis
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Retail Pharmacies
    • 6.4.3. Online Pharmacies

Chapter 7. Global Antihypertensive Drugs Market, Regional Analysis

  • 7.1. Antihypertensive Drugs Market, Regional Market Snapshot
  • 7.2. North America Antihypertensive Drugs Market
    • 7.2.1. U.S. Antihypertensive Drugs Market
      • 7.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Antihypertensive Drugs Market
  • 7.3. Europe Antihypertensive Drugs Market Snapshot
    • 7.3.1. U.K. Antihypertensive Drugs Market
    • 7.3.2. Germany Antihypertensive Drugs Market
    • 7.3.3. France Antihypertensive Drugs Market
    • 7.3.4. Spain Antihypertensive Drugs Market
    • 7.3.5. Italy Antihypertensive Drugs Market
    • 7.3.6. Rest of Europe Antihypertensive Drugs Market
  • 7.4. Asia-Pacific Antihypertensive Drugs Market Snapshot
    • 7.4.1. China Antihypertensive Drugs Market
    • 7.4.2. India Antihypertensive Drugs Market
    • 7.4.3. Japan Antihypertensive Drugs Market
    • 7.4.4. Australia Antihypertensive Drugs Market
    • 7.4.5. South Korea Antihypertensive Drugs Market
    • 7.4.6. Rest of Asia Pacific Antihypertensive Drugs Market
  • 7.5. Latin America Antihypertensive Drugs Market Snapshot
    • 7.5.1. Brazil Antihypertensive Drugs Market
    • 7.5.2. Mexico Antihypertensive Drugs Market
  • 7.6. Rest of The World Antihypertensive Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Boehringer Ingelheim International GmbH
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Merck & Co., KGaA
    • 8.2.3. Johnson and Johnson
    • 8.2.4. Bayer AG
    • 8.2.5. Pfizer, Inc.
    • 8.2.6. Takeda Pharmaceutical Co. Ltd.
    • 8.2.7. AstraZeneca plc
    • 8.2.8. Daiichi Sankyo Company, Ltd.
    • 8.2.9. Sanofi S.A.
    • 8.2.10. Novartis International AG

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
Back to Top
전화 문의
F A Q